{"id":"W4413043048","doi":"10.1183/23120541.01390-2024","title":"Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two years","year":2025,"lang":"en","type":"article","venue":"ERJ Open Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Association of Occupational Therapists","funders":"GlaxoSmithKline","keywords":"Medicine; Mepolizumab; Asthma; Confidence interval; Bronchodilator; Internal medicine; Corticosteroid; Prospective cohort study; Emergency department; Cohort; Pediatrics; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00108821,0.0003539576,0.00133676,0.0001539333,0.0001639961,0.000410389,0.0001936988,0.0005763681,0.00138689],"category_scores_gemma":[0.001245026,0.0001379455,0.001142117,0.0001683234,0.0001775955,0.0004394595,0.0002554427,0.0009671343,0.0001545625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002237976,"about_ca_system_score_gemma":0.0003223237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005375571,"about_ca_topic_score_gemma":0.001295869,"domain_scores_codex":[0.9996543,0.0001294073,0.00003438245,0.00006485263,0.00004091398,0.00007616704],"domain_scores_gemma":[0.9989712,0.0002879426,0.0004166152,0.00004321456,0.00003471136,0.000246463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6619086,0.007446197,0.09908097,0.002163307,0.004652997,0.0004647323,0.00019372,0.001105994,0.01186032,0.0002097821,0.002077853,0.2088355],"study_design_scores_gemma":[0.1001941,0.2157743,0.6697369,0.0003684471,0.005016243,0.001062384,0.0001304605,0.001407207,0.002260671,0.0003420161,0.00364957,0.00005765651],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818819,0.01661428,0.0001182469,0.0003357925,0.00008776754,0.00007287059,0.0002020301,0.00001665931,0.00067045],"genre_scores_gemma":[0.9968073,0.002183385,0.0001179671,0.0002351247,0.0001095492,0.00005817941,0.0001844927,0.000001491102,0.0003025953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00138689,"threshold_uncertainty_score":0.005755126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03001477315821949,"score_gpt":0.3442717984978137,"score_spread":0.3142570253395942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}